Pharmaceutical Technology's Annual Employment Survey - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Annual Employment Survey
Nearly 1300 pharmaceutical employees provide insights into the issues most relevant to their jobs and the state of the industry workforce today.

Pharmaceutical Technology

Table I: Results overview: profile of a typical industry employee.
Their hours, ranks, and pay scales may vary, but pharmaceutical employees agree on many of the best and worst aspects of their jobs. Thanks to the nearly 1300 industry employees who participated in this year's survey, Pharmaceutical Technology highlights the issues directly affecting workers in the industry, including demographic information, education and work experience, salary and benefits, and attitudes toward current employment. Some overall results are summarized in Table I. When reviewing salary and benefits information, readers should take into account the range of experience, job functions, and educational certifications represented. No one statistic should be used for comparison without taking these factors into account.


Figure 1. Percentage of male and female respondents.
Gender and age. Of the total number of responses, 67% overall came from men (see Figure 1). The average respondent age is 44 years. These values have remained relatively constant throughout the history of the survey.

Work location. Approximately 85% of the survey responses were received from industry workers in the United States, including Puerto Rico. Of these, approximately 14% work in New Jersey, 10% in Pennsylvania, and 9% in California; 6.5% each in New York, North Carolina, and Massachusetts; and 5.8% in Illinois. All other states each accounted for 3% or less of the total US responses. Other world regions represented less than 1% each of the total number of responses. Readers should take into account the number of responses received from each region when noting the results of this survey, especially salary results according to US region.

Figure 2. Highest level of education
Education and work experience. Fifty-four percent of employees have a degree beyond a bachelor's degree (see Figure 2). The most common fields of study were analytical chemistry (16%), biology or biology-related fields (12%), and pharmaceutics or pharmacy (12%). Nine percent of respondents earned degrees in engineering or engineering management. And 11% said they had studied in a field unrelated to pharmaceutical science or industry.

More than 72% of respondents said their experience prepared them very well for their current job functions, but only 34% said the same for their educations. Pharmaceutical employees reported an average of 19 years of professional work experience, including postdoctoral study.


Type of employer. As in previous Pharmaceutical Technology employment surveys, a preponderance of respondents (88%) indicated that they work in private industry, with 36% working at companies employing more than 10,000 people total. The percentage of respondents from academia or government was approximately 3% each. Therefore, the information provided in this article, including salary and attitudes toward current employment, best represents those working in the private sector.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here